Skip to content

Treasury Stock at other companies

Baxter International logo
Baxter InternationalBAX
$10.74B-1.8%
UFP Technologies logo
UFP TechnologiesUFPT
$587K0.0%
ICU Medical logo
ICU MedicalICUI
$25.18M+41,872%
AptarGroup logo
AptarGroupATR
$1.05B+55.6%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$1.38B+18.6%
Nordson logo
NordsonNDSN
$2.33B+13.9%

Other financials

Income statement

See full
Revenue$11.8M+22.1%
Gross profit$7.2M+19.6%
Operating income-$864.9K+30.5%
Net income-$807.1K+30.8%
EPS (diluted)-$0.02+33.3%

Balance sheet

See full
Cash & equivalents$8.8M+0.4%
Total debt$3.5M-2.8%
Total equity$16.9M+3.5%
Total assets$28.6M+5.1%

Cash flow

See full
Operating cash flow$14.7K+106%
CapEx$46.2K-89.6%
Free cash flow-$31.5K+95.4%

Valuation

See full
Market cap$206.24M+24.9%
Enterprise value$200.96M+25.1%
P/S4.8×+0.3×

Profitability

See full
Gross margin61.9%-1.6pp
Operating margin-6%-2.3pp
Net margin-5.3%-2.1pp
FCF margin-37.1%+23.7pp

Returns & leverage

See full
Return on equity-13.7%-4.8pp
Debt / equity0.2×0.0×
Current ratio2.3×-0.1×

Where this comes from

Reported directly by KORU Medical Systems in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockValue.

The official record: KORU Medical Systems’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about KORU Medical Systems's treasury stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KORU Medical Systems's treasury stock?
KORU Medical Systems (KRMD) reported treasury stock of $5.55M in Q1 2026.
How has KORU Medical Systems's treasury stock changed year-over-year?
KORU Medical Systems's treasury stock increased by 42.9% year-over-year, from $3.88M to $5.55M.
What is the long-term trend for KORU Medical Systems's treasury stock?
Over 5 years (2020 to 2025), KORU Medical Systems's treasury stock has grown at a 0.2% compound annual growth rate (CAGR), from $3.84M to $3.88M.
What does treasury stock mean?
Shares repurchased by the company and held in treasury, reducing equity. Recorded at cost and presented as a negative equity component.